Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

NCT00277524 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT00277524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00277524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Observational
Overall status
Terminated
Start date
August 31, 2005
Completion date
November 30, 2010
Enrollment
3,032 (actual)
Sites
113

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, heart failure, congestive, tachycardia, ventricular, ventricular dysfunction, ventricular fibrillation